Related Experiment Video
Updated: Sep 30, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.6K
Risk factor management of atrial fibrillation using mHealth: The Atrial Fibrillation - Helping Address Care with
Lindsey R Mitrani1, Isaac Goldenthal1, Jamie Leskowitz1
1Division of Cardiology, Department of Medicine, Columbia University, Vagelos College of Physicians and Surgeons, New York, New York.
Cardiovascular Digital Health Journal
|March 10, 2022
Summary
The Atrial Fibrillation Helping Address Care with Remote Technology (AF-HEART) intervention demonstrated feasibility in managing atrial fibrillation (AF) risk factors through remote monitoring and telehealth, leading to improved quality of life and reduced symptoms.
Area of Science:
- Cardiology
- Digital Health
- Remote Patient Monitoring
Background:
- Personalized treatment of atrial fibrillation (AF) risk factors using mHealth and telehealth can enhance patient outcomes.
- Remote interventions show promise for improving the management of chronic conditions like AF.
Purpose of the Study:
- To assess the feasibility of the Atrial Fibrillation Helping Address Care with Remote Technology (AF-HEART) intervention.
- Evaluate the impact of AF-HEART on heart rhythm tracking, risk factor reduction (weight, alcohol, BP, sleep apnea), AF symptom severity, and quality of life (QOL).
Main Methods:
- The AF-HEART intervention involved 20 AF patients over 6 months.
- Included remote tracking of heart rhythm, weight, and blood pressure (BP).
- Utilized televisits for dietary counseling and referrals for sleep apnea and hypertension management.
Main Results:
- Patients achieved an average weight loss of 3.5 kg (P = .005).
- Significant improvements were observed in quality of life scores (SF-12, EQ-5D, AFEQT) and AF symptom severity (AFSS).
- Weight loss correlated significantly with reduced AF symptom severity (r = -0.45 to -0.49, P = .03-.05).
Conclusions:
- The AF-HEART intervention is feasible for remote tracking and management of AF risk factors.
- The intervention successfully facilitated weight loss, symptom reduction, and improved QOL in AF patients.
- A larger randomized study is planned to further validate the AF-HEART intervention's efficacy.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
131
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
131
01:26Atherosclerosis III: Management
56
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
56
01:21Rheumatic Heart Disease III: Medical Management
47
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
47
01:26Mitral Stenosis III: Medical Management
32
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
32
01:30Heart Failure V: Medical Management
36
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36
01:22Mitral Valve Prolapse II: Assessment and Management
53
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
53